Article
Limited clinical utility of HLA-Cw6 genotyping for outcome prediction in psoriasis…
Psoriasis: Targets and Therapy · 2018 · Anzengruber F, Ghosh A, Maul JT, Drach M, Navarini AA
Key facts
| Title | Limited clinical utility of HLA-Cw6 genotyping for outcome prediction in psoriasis patients under ustekinumab therapy: a monocentric, retrospective analysis |
|---|---|
| First author | Anzengruber F, Ghosh A, Maul JT, Drach M, Navarini AA |
| Journal | Psoriasis: Targets and Therapy |
| Published | Mar 23, 2018 |
| DOI | 10.2147/PTT.S161437 |
| Devices mentioned | K791153 |
| Product codes mentioned | JAK |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1